Researchers are running trials on how hormone therapies affect trans people that will also benefit healthcare for the wider population
When Cameron Whitley was diagnosed with kidney failure seven years ago, the news came as a shock. But the situation was about to get worse. His doctor decided the diagnosis meant Whitley’s hormone therapy had to stop.
As a transgender man, now 42, who had taken testosterone for 10 years, the impact was brutal.
